Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy.
Transfus Apher Sci
; 59(6): 102993, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-899612
ABSTRACT
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopathogenesis and coagulopathy induced by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 patients.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Plasma Exchange
/
Blood Coagulation Disorders
/
Plasmapheresis
/
Pandemics
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Transfus Apher Sci
Journal subject:
Hematology
Year:
2020
Document Type:
Article
Affiliation country:
J.transci.2020.102993
Similar
MEDLINE
...
LILACS
LIS